DE2608226A1 - AGENTS WITH PHYSIOLOGICAL COOLING EFFECT - Google Patents

AGENTS WITH PHYSIOLOGICAL COOLING EFFECT

Info

Publication number
DE2608226A1
DE2608226A1 DE19762608226 DE2608226A DE2608226A1 DE 2608226 A1 DE2608226 A1 DE 2608226A1 DE 19762608226 DE19762608226 DE 19762608226 DE 2608226 A DE2608226 A DE 2608226A DE 2608226 A1 DE2608226 A1 DE 2608226A1
Authority
DE
Germany
Prior art keywords
cooling effect
carbon atoms
acid
esters
menthol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19762608226
Other languages
German (de)
Inventor
Kurt Dr Bauer
Juergen Dr Bruening
Helmut Dr Grueb
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Haarmann and Reimer GmbH
Original Assignee
Haarmann and Reimer GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Haarmann and Reimer GmbH filed Critical Haarmann and Reimer GmbH
Priority to DE19762608226 priority Critical patent/DE2608226A1/en
Priority to JP1876477A priority patent/JPS52105223A/en
Priority to NL7702074A priority patent/NL7702074A/en
Priority to FR7705787A priority patent/FR2342057A1/en
Publication of DE2608226A1 publication Critical patent/DE2608226A1/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11BPRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B9/00Essential oils; Perfumes
    • C11B9/0026Essential oils; Perfumes compounds containing an alicyclic ring not condensed with another ring
    • C11B9/0034Essential oils; Perfumes compounds containing an alicyclic ring not condensed with another ring the ring containing six carbon atoms

Description

HAARMANN & REIMERHAARMANN & REIMER

■l'■ l '

B/Kp/PfB / Kp / Pf

Mittel mit physiologischer KühlwirkungMeans with a physiological cooling effect

Die Erfindung betrifft Mittel mit physiologischer Kühlwirkung auf Haut und Schleimhäute des Körpers.The invention relates to agents with a physiological cooling effect on the skin and mucous membranes of the body.

Menthol, der Hauptinhaltstoff der Pfefferminzöle zeichnet sich durch seine hervorragende Kühlwirkung auf Haut und Schleimhäute des Körpers aus. Seine Kühlwirkung beruht dabei nicht au:? einer latenten Verdampfungswärme, sondern entsteht durch direkte Einwirkung der Verbindung auf die Nervenenden von Kälterezeptoren. Die Geruchs- und Geschmackseigenschaften von Menthol schränken jedoch seine Verwendung ein bzw. machen sie sogar in einigen Fällen unmöglich. Der Geruch nach Pfefferminz ist für verschiedene Anwendungsgebiete zu spezifisch und zu scharf und tränen- und sohleimhautreizend. Für andere Anwendungsgebiete ist der Geschmack zu scharf und bitter. Nachteilig wirkt sich oftauch die große Flüchtigkeit von Menthol aus. Menthol, the main ingredient in peppermint oils, is characterized by its excellent cooling effect on the skin and mucous membranes of the body. Its cooling effect is not based on:? a latent heat of vaporization, but arises from the direct action of the compound on the nerve endings of cold receptors. However, the smell and taste properties of menthol limit its use or, in some cases, even make it impossible. The smell of peppermint is too specific and too pungent for various areas of application and irritates tears and the mucous membrane of the sole. For other applications, the taste too sharp and bitter is. The great volatility of menthol often has a disadvantageous effect.

Es hat daher nicht an Versuchen gefehlt, Stoffe zu findan, die den positiven Effekt der Kühlwirkung besitzen, ohne die oben geschilderten Nachteile des Menthols aufzuweisen. So werden z.B. in der DT-OS 2 202 535 p-Menthan-3-carboxamid und Ester der p-Menthan-3-carbonsäure, in der DT-OS 2 205 255 N-substituierte p-Methan-3-carboxamide, in der DT-OS 2 317 538 substituierte Amide, in der DT-OS 2 334 985 cyclische und acyclische SulfoxideThere has therefore been no lack of attempts to find substances which have the positive effect of cooling without having the disadvantages of menthol described above. Thus, for example, in DT-OS-p-menthane-3-carboxamide 2,202,535 and esters of p-menthane-3-carboxylic acid, in the DT-OS 2205255 N-substituted p-methane-3-carboxamides in which DT-OS 2,317,538 substituted amides, in DT-OS 2,334,985 cyclic and acyclic sulfoxides

HR 62 - 1 -HR 62 - 1 -

709836/0088709836/0088

und Sulfone und in der DT-OS 2 345 156 substituierte Phosphinoxide vorgeschlagen.and sulfones and phosphine oxides substituted in DT-OS 2,345,156 suggested.

Die Verbindungen, die dem gesetzten Ziel, eine Kühlwirkung aufzuweisen und dabei geruch- und geschmacklos zu sein, teilweise sehr nahekommen, haben jedoch den Nachteil, daß sie weder natürlich vorkommende Stoffe sind, noch vom menschlischen Organismus zu natürlich vorkommenden Stoffen abgebaut werden können. Sie sind daher physiologisch und lebensmittelrechtlich bedenklich. Zudem sind sie teilweise sehr teuer, da sie nur in vielstufigen Verfahren herstellbar sind.The compounds that meet the set goal of having a cooling effect while being odorless and tasteless, in part come very close, however, have the disadvantage that they are neither naturally occurring substances nor of human nature Organism can be broken down into naturally occurring substances. They are therefore physiological and food law dubious. In addition, they are sometimes very expensive because they can only be produced in multi-stage processes.

Die bisher vorgeschlagenen Derivate des Menthols, die entweder natürlich vorkommen oder vom Organismus zu natürlich vorkommenden Stoffen abgebaut werden, erfüllen die an sie gestellten Anforderungen nur unvollkommen. So weist das in der DT-OS 2 022 364 vorgeschlagene 1-Menthyläthylcarbonat einen orangenartigen Geruch auf, der in der DT-OS 2 433 165 vorgeschlagenen N-Acetylglycin-menthylester sowie die in der DT-OS 2 339 661 vorgeschlagenen Mentholester von heterocyclischen Carbonsäuren sind bitter und die in der US-PS 3 830 vorgeschlagenen Menthylketoester sind z. T. anhaltend bitter und weisen nicht die gewünschte Kühlwirkung auf.The derivatives of menthol proposed so far, which either occur naturally or are broken down by the organism to form naturally occurring substances, only incompletely meet the requirements placed on them. For example, the 1-menthyl ethyl carbonate proposed in DT-OS 2 022 364 has an orange-like odor, the N-acetylglycine menthyl ester proposed in DT-OS 2 433 165 and the menthol esters of heterocyclic carboxylic acids proposed in DT-OS 2 339 661 are bitter and the menthyl ketoesters proposed in U.S. Patent 3,830 are e.g. T. persistently bitter and do not have the desired cooling effect.

Es wurde nun überraschend gefunden, daß Ester aus Menthol und natürlich vorkommenden Hydroxycarbonsäuren mit 2 bis 6 C-Atomen, die gegebenenfalls an der Hydroxygruppe der Carbonsäure verestert sind, geruch- und geschmacklos sind und eine ausgezeichnete, insbesondere langanhaltende Kühlwirkung aufweisen. It has now been found, surprisingly, that esters of menthol and naturally occurring hydroxycarboxylic acids with 2 to 6 carbon atoms, which are optionally esterified on the hydroxyl group of the carboxylic acid, are odorless and tasteless and have an excellent, especially long-lasting cooling effect.

Die Erfindung betrifft daher Mittel mit physiologischer Kühlwirkung auf Haut und Schleimhäute des Körpers, die dadurchThe invention therefore relates to agents with a physiological cooling effect on the skin and mucous membranes of the body that this causes

HR 62 - 2 -HR 62 - 2 -

709836/0088709836/0088

gekennzeichnet sind, daß sie Ester aus Menthol und natürlich vorkommenden Hydroxycarbonsäuren mit 2 bis 6 C-Atomen, die gegebenenfalls ihrerseits an der Hydroxygruppe mit 1 bis 4 C-Atome aufweisenden Carbonsäuren verestert sind, enthalten.are characterized in that they are esters of menthol and naturally occurring hydroxycarboxylic acids with 2 to 6 carbon atoms, the are optionally in turn esterified on the hydroxyl group with 1 to 4 carbon atoms containing carboxylic acids.

Als natürlich vorkommende Hydroxycarbonsäuren mit 2 bis 6 C-Atomen seien beispielsweise genannt: Glycolsäure, ß-Hydroxybuttersäure, CC- Hydr oxy is ovaler iansäure, (t-Hydroxy-ct-methylvaleriansäure, (t-Hydroxy-JT-methylvaleriansäure, CG-Hydroxycapronsäure und ß-Hydroxycapronsäure, insbesondere aber Milchsäure.Examples of naturally occurring hydroxycarboxylic acids with 2 to 6 carbon atoms are: glycolic acid, ß-hydroxybutyric acid, CC- Hydroxy is ovalic acid, (t-Hydroxy-ct-methylvaleric acid, (t-Hydroxy-JT-methylvaleric acid, CG-hydroxycaproic acid and ß-hydroxycaproic acid, but especially lactic acid.

Als 1 bis 4-C-Atome aufweisende Carbonsäuren, mit denen die Hydroxygruppe der Hydroxycarbonsäuren verestert sein kann, seien vor allem Ameisensäure, Essigsäure und Propionsäure genannt.As carboxylic acids having 1 to 4 carbon atoms, with which the hydroxyl group of the hydroxycarboxylic acids can be esterified, formic acid, acetic acid and propionic acid are especially mentioned.

Die erfindungsgemäß zu verwendenden Ester sind nur zum Teil neu. Von den beschriebenen Estern war jedoch unbekannt, daß sie eine physiologische Kühlwirkung auf Haut und Schleimhäute des Körpers ausüben. Die Ester können nach herkömmlichen Verfahren hergestellt werden, beispielsweise durch sauer katalysierte Veresterung von Menthol mit Hydroxycarbonsäuren oder durch Reduktion von Ketocarbonsäurementhylestern.Die Ketocarbonsäurementhylester sind ihrerseits z.B. durch Umesterung von Ketocarbonsäurealkylestern mit Menthol erhältlich. Die Veresterung der Hydroxygruppe der Hydroxycarbonsäure mit den 1 bis 4 C-Atome aufweisenden Carbonsäuren wird zweckmäßigerweise als letzte Stufe durchgeführt.The esters to be used according to the invention are only partly new. Of the esters described, however, it was unknown that they were one have a physiological cooling effect on the skin and mucous membranes of the body. The esters can be prepared by conventional methods , for example by acid-catalyzed esterification of menthol with hydroxycarboxylic acids or by reduction of Keto-Mementhyl Ester are in turn obtainable e.g. by transesterification of ketocarboxylic acid alkyl esters with menthol. The esterification the hydroxyl group of the hydroxycarboxylic acid with the 1 to 4 carbon atoms having carboxylic acids is expediently as last stage carried out.

Die erfindungsgemäß zu verwendenden Ester weisen asymmetrische C-Atome auf; bei ihnen kann daher optische Isomerie auftreten. Je nach Ausgangsmaterial und angewendeten Herstellungsmethoden können sie als Gemische der optischen Isomeren oder als reine Isomere vorliegen. Die Kühlwirkung der Isomeren kann unterschiedlich sein, so daß das eine oder andere Isomere bevorzugt sein kann.The esters to be used according to the invention have asymmetric carbon atoms; optical isomerism can therefore occur in them. Depending on the starting material and the manufacturing methods used, they can be used as mixtures of the optical isomers or as pure Isomers exist. The cooling effect of the isomers can be different, so that one or the other isomer is preferred can be.

HR 62 - 3 -HR 62 - 3 -

709836/0088709836/0088

Die erfindungsgemaßen Kühlmittel können überall da angewendet werden, wo eine physiologische Kühlwirkung erwünscht ist. Zusammensetzungen, in denen solche Kühlmittel gern verwendet werden sind beispielsweise Genußmittel wie Kaugummi, Kautabak, Zigaretten, Getränke, Eis, Konfekt usw., pharmazeutische Präparate, Körperpflegemittel oder kosmetische Präparate, wie Zahnreinigungsmittel, Mundwasser, Gurgelpräparate, Parfüms, Puder, Lotionen, Salben, OeIe, Cremes, Rasierwässer. Shampoos usw.The coolants according to the invention can be used anywhere where a physiological cooling effect is desired. Compositions in which such coolants like to be used Examples of luxury items such as chewing gum, chewing tobacco, cigarettes, beverages, ice cream, confectionery, etc., pharmaceutical preparations, personal care products or cosmetic preparations such as dentifrices, mouthwashes, gargle preparations, perfumes, powders, lotions, Ointments, oils, creams, aftershave lotions. Shampoos etc.

Die Endprodukte enthalten die erfindungsgemäß zu verwendenden Ester in einer Menge, die ausreicht, um die Kälterezeptoren zu stimulieren und das erwünschte Kälteempfinden hervorzurufen. In der Regel kommen 0,1 bis 5 Gewichtsprozent bezogen auf das Gewicht der Gesamtzusammensetzung zur Anwendung. Neben der Kühlwirkung weisen die erfindungsgemäßen Ester, insbesondere das Menthyllactat, eine Enhancerwirkung, d.h. eine geschmackverstärkende Wirkung für andere Geschmackstoffe auf. Beispielsweise gestattet der Zusatz einer auch unterhalb des Schwellenwertes für eine physiologische Kühlwirkung liegenden Menge der erfindungsgemäß zu verwendenden Ester die z.B. Kaugummis oder Dentominten als Geschmackstoffe einverleibte Menge an Pfefferminzöl, Krauseminzöl, oder anderen Geschmackstoffen herabzusetzen,ohne daß eine Abweichung des GeBchmackes eintritt.The end products contain the esters to be used according to the invention in an amount sufficient to protect the cold receptors to stimulate and induce the desired sensation of cold. As a rule, 0.1 to 5 percent by weight based on the weight of the total composition are used. In addition to the The esters according to the invention, in particular menthyl lactate, have an enhancing effect, i.e. a taste-enhancing effect Effect on other flavors. For example, the addition of a also allows below the threshold value for a physiological cooling effect lying amount of the invention to be used esters such as chewing gum or Amount of peppermint oil incorporated into dentists as flavorings, Spearmint oil, or other flavorings, without degrading that there is a deviation in taste.

Die folgenden Beispiele erläutern die Anwendung der erfindungsgemäßen Kühlmittel in verschiedenen Zusammensetzungen.Bei den Prozentangaben handelt es sich, sofern nichts anderes angegeben 1st um Gewichtsprozent.The following examples explain the use of the coolants according to the invention in various compositions. Unless otherwise stated, the percentages are percentages by weight.

HR 62 - 4 -HR 62 - 4 -

709836/0088709836/0088

Beispiel 1
Zahnpasta
example 1
toothpaste

Folgende Komponenten wurden in üblicher Weise vermischt:The following components were mixed in the usual way:

Glycerin DAB 6 20 %Glycerin DAB 6 20%

p-Hydroxybenzoesäuremethylester 0,15 % p-hydroxybenzoic acid methyl ester 0.15 %

Carboxymethylcellulose 1,2 % Carboxymethyl cellulose 1.2 %

Saccharin 0,2 % Saccharin 0.2 %

Dicalciumphosphat (wasserhaltig) 48 % Dicalcium phosphate (containing water) 48 %

Natriumlaurylsulfat 2,2 % Sodium Lauryl Sulphate 2.2 %

Geschmackstoffe 1,0 % Flavors 1.0 %

Wasser 100 % Water 100 %

Vor Beendigung des Mischvorgangs wurde 1 % 1-Menthyllactat zugesetzt. Die Zahnpasta zeichnet sich durch eine Kühlwirkung aus.Before the end of the mixing process, 1 % 1-menthyl lactate was added. The toothpaste is characterized by a cooling effect.

Beispiel 2
Kaugummi
Example 2
chewing gum

In eine handelsübliche Kaugummibase wurden 0,3 % O-Acetylmilchsäure-1-menthylester eingearbeitet. Die Kaugummimasse erzeugt im Munde ein Kühlegefühl.In a commercially available gum base 0.3% O-Acetylmilchsäure-1-menthyl ester were incorporated. The chewing gum mass creates a feeling of coolness in the mouth.

Beispiel 3Example 3
Fondantfondant

1 % 1-Menthyllactat wurde in eine handelsübliche Fondantgrundbase eingearbeitet. Die Fondantmasse weist einen angenehm erfrischenden Geschmack auf.1 % 1-menthyl lactate was incorporated into a commercially available fondant base. The fondant mass has a pleasantly refreshing taste.

HR 62 - 5 -HR 62 - 5 -

709836/0088709836/0088

Beispiel 4
Mundwasser
Example 4
Mouthwash

Ein Mundwasserkonzentrat wurde aus folgenden Bestandteilen hergestellt:A mouthwash concentrate was made from the following ingredients:

Aethanol 60 % Ethanol 60 %

Bromchlorophen 0,05 % Bromochlorophene 0.05 %

Polyoxyäthylen-Sorbitan-monolaureat 1 % Polyoxyethylene sorbitan monolaureate 1 %

Allantoin 0,2 % Allantoin 0.2 %

Saccharin 0,2 %Saccharin 0.2%

Geschmackstoffe auf 100 % Flavors to 100 %

Der Mischung wurden 5 % 1-Menthyllactat zugesetzt. Für die Herstellung von Mundwasser wurde das Konzentrat mit dem 10-fachen seines Volumens an Wasser verdünnt. Das Mundwasser zeichnet sich durch eine Kühlwirkung aus.5 % 1-menthyl lactate was added to the mixture. For the preparation of mouthwash, the concentrate was diluted with 10 times its volume of water. The mouthwash is characterized by a cooling effect.

Ein gleichartig wirkendes Mundwasser wurde erhalten, wenn anstelle der 5 % 1-Menthyllactat die gleiche Menge Glycolsäure-, ß-Hydroxybuttersäure-, <X< -Hydroxyisovaleriansäure-, A -Hydroxy-ct- methylvaleriansäure-, o& -Hydroxy-^-methylvaleriansäure-, flt-Hydroxycapronsäure- oder ß-Hydroxycapronsäure-1-menthylester eingesetzt wurde. A similarly acting mouthwash was obtained if, instead of the 5 % 1-menthyl lactate, the same amount of glycolic acid, ß-hydroxybutyric acid, <X < -hydroxyisovaleric acid, A -hydroxy-ct- methylvaleric acid-, o & -hydroxy- ^ - methylvaleric acid- , flt-hydroxycaproic acid or ß-hydroxycaproic acid 1-menthyl ester was used.

Beispiel 5Example 5

Ge s ichtsre inigungslotion Face cleansing lotion

Eine Gesichtsreinigungslotion wurde aus folgenden Komponenten hergestellt: A facial cleansing lotion was made from the following components:

HR 62 - 6 -HR 62 - 6 -

709836/0088709836/0088

AethanolEthanol 26,326.3 1-Menthyllactat1-menthyl lactate 11 ParfümölPerfume oil 0,10.1 EmulgatorEmulsifier 44th 1,2-Propylenglykol1,2 propylene glycol 11 AllantoinAllantoin 0,050.05 MilchsäureLactic acid 0,050.05 Wasserwater 67,567.5

Die Lotion ruft auf der Gesichtshaut eine Kühlwirkung hervor.The lotion has a cooling effect on the skin of the face.

Beispiel 6
After-Shave-Lotion
Example 6
After shave lotion

Eine After-Shave-Lotion wurde aus folgenden Komponenten hergestellt: An after-shave lotion was made from the following components:

Aethanol 55,5 % Ethanol 55.5 %

1-Menthyllactat 1,5 % 1-menthyl lactate 1.5 %

Parfümöl 0,5 % Perfume oil 0.5 %

Emulgator 0,3 %Emulsifier 0.3%

Wasser 39,8 % Water 39.8 %

Allantoin 0,2 % Allantoin 0.2 %

1,2-Propylenglykol 2 % 1,2-propylene glycol 2 %

Milchsäure 0,2 %Lactic acid 0.2%

Die Lotion ruft bei der Auftragung auf das Gesicht eine Kühlwirkung hervor.The lotion produces a cooling effect when applied to the face.

Ein gleichartig wirkendes Präparat wurde erhalten;wenn anstelle von 1-Menthyllactat die gleiche Menge 0-Formylmilchsäure-1-menthylester eingesetzt wurde.A similarly acting preparation was obtained; if instead of 1-menthyl lactate the same amount of 0-formyllactic acid 1-menthyl ester was used.

HR 62 - 7 -HR 62 - 7 -

709836/0088709836/0088

Beispiel 7
Klarshampoo
Example 7
Clear shampoo

Ein Klarshampoo wurde aus folgenden Komponenten hergestellt:A clear shampoo is made from the following components:

Fettsäureamidoalkylbetain 60 % Fatty acid amidoalkyl betaine 60 %

Wasser 35,2 % Water 35.2 %

Konservierungsmittel 0,2 % Preservative 0.2 %

d,1-Menthyllactat 2 % d, 1-menthyl lactate 2 %

Parfümöl 0,5 %Perfume oil 0.5%

Kokosfettsäurediäthanolamid 2 % Coconut fatty acid diethanolamide 2 %

Das Shampoo erzeugt auf der Kopfhaut eine starke Kühlwirkung.The shampoo creates a strong cooling effect on the scalp.

Beispiel 8
After-Bath-Freshener
Example 8
After bath freshener

Ein After-Bath-Freshener wurde aus folgenden Bestandteilen hergestellt:An after-bath freshener was made from the following components:

AethanolEthanol 5050 1-Menthyllactat1-menthyl lactate 1,51.5 ParfümölPerfume oil 22 Nachfetter auf Lanolin-BasisLanolin-based refatting agent 22 EmulgatorEmulsifier 1,51.5 Wasserwater 4343

Der After-Bath-Freshener zeichnet sich durch eine angenehm erfrischende Wirkung aus.The after-bath freshener is characterized by a pleasantly refreshing effect.

HR 62 - 8 -HR 62 - 8 -

709836/0088709836/0088

Claims (6)

Patentansprüche:Patent claims: 1. Mittel mit physiologischer Kühlwirkung auf Haut und Schleimhäute des Körpers, dadurch gekennzeichnet, daß sie Ester aus Menthol und natürlich vorkommenden Hydroxycarbonsäuren mit 2 bis 6 C-Atomen, die gegebenenfalls ihrerseits an der Hydroxygruppe mit 1 bis 4 C-Atome aufweisenden Carbonsäuren verestert sind, enthalten.1. Means with a physiological cooling effect on the skin and mucous membranes of the body, characterized in that it contains esters of menthol and naturally occurring hydroxycarboxylic acids with 2 up to 6 carbon atoms, which in turn is esterified on the hydroxyl group with 1 to 4 carbon atoms containing carboxylic acids included. 2. Mittel gemäß Anspruch 1, enthaltend als Kühlreagenz Menthyllactat.2. Means according to claim 1, containing as a cooling reagent Menthyl lactate. 3. Verwendung von Estern aus Menthol und natürlich vorkommenden Hydroxycarbonsäuren mit 2 bis 6 C-Atomen, die gegebenenfalls ihrerseits an der Hydroxygruppe mit 1 bis 4 C-Atome aufweisenden Carbonsäuren verestert sind, als Mittel mit physiologischer Kühlwirkung auf Haut und Schleimhäute des Körpers.3. Use of esters from menthol and naturally occurring hydroxycarboxylic acids with 2 to 6 carbon atoms, which may be are in turn esterified on the hydroxyl group with 1 to 4 carbon atoms having carboxylic acids, as agents physiological cooling effect on the skin and mucous membranes of the body. 4. Verwendung von Menthyllactat gemäß Anspruch 3.4. Use of menthyl lactate according to claim 3. 5. Kühlmittelhaltige Zusammensetzungen gekennzeichnet durch einen Gehalt an Kühlmitteln gemäß Anspruch 1 und 2. 5. Coolant-containing compositions characterized by a content of coolants according to Claims 1 and 2. 6. Kühlmittelhaltige Zusammensetzungen gemäß Anspruch 5, dadurch gekennzeichnet, daß sie die Kühlmittel gemäß Anspruch 1 und 2 in einer Menge von 0,1 bis 5 Gewichtsprozent bezogen auf das Gewicht des Präparates enthalten. 6. Coolant- containing compositions according to claim 5, characterized in that they contain the coolant according to claim 1 and 2 in an amount of 0.1 to 5 percent by weight based on the weight of the preparation. HR 62 - 9 -HR 62 - 9 - 709836/0088709836/0088 ORIGINAL INSPECTEDORIGINAL INSPECTED
DE19762608226 1976-02-28 1976-02-28 AGENTS WITH PHYSIOLOGICAL COOLING EFFECT Pending DE2608226A1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
DE19762608226 DE2608226A1 (en) 1976-02-28 1976-02-28 AGENTS WITH PHYSIOLOGICAL COOLING EFFECT
JP1876477A JPS52105223A (en) 1976-02-28 1977-02-24 Material having physiological cooling action and its utilization
NL7702074A NL7702074A (en) 1976-02-28 1977-02-25 AGENT AND PREPARATION WITH A PHYSIOLOGICAL COOLING EFFECT ON THE SKIN AND MUSCLES OF THE BODY.
FR7705787A FR2342057A1 (en) 1976-02-28 1977-02-28 Compsns. having physiological cooling activity - contg. menthol esters of natural hydroxycarboxylic acids opt. esterified at hydroxyl gp. (NL 3.8.77)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19762608226 DE2608226A1 (en) 1976-02-28 1976-02-28 AGENTS WITH PHYSIOLOGICAL COOLING EFFECT

Publications (1)

Publication Number Publication Date
DE2608226A1 true DE2608226A1 (en) 1977-09-08

Family

ID=5971145

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19762608226 Pending DE2608226A1 (en) 1976-02-28 1976-02-28 AGENTS WITH PHYSIOLOGICAL COOLING EFFECT

Country Status (4)

Country Link
JP (1) JPS52105223A (en)
DE (1) DE2608226A1 (en)
FR (1) FR2342057A1 (en)
NL (1) NL7702074A (en)

Cited By (85)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5266592A (en) * 1991-04-05 1993-11-30 Haarmann & Reimer Gmbh Compositions which have a physiological cooling effect, and active compounds suitable for these compositions
WO1996014840A1 (en) * 1994-11-14 1996-05-23 Zyma S.A. Use of menthyl lactate as a pain reliever
WO1997002116A1 (en) * 1995-06-30 1997-01-23 The Gillette Company Shaving aid composite with a non-volatile cooling agent
WO1997007771A1 (en) * 1995-08-29 1997-03-06 V. Mane Fils S.A. Refreshing compositions
WO1997042945A1 (en) * 1996-05-13 1997-11-20 Novartis Consumer Health S.A. Oral pharmaceutical compositions
WO1997042944A1 (en) * 1996-05-13 1997-11-20 Novartis Consumer Health S.A. Topical composition
WO1998002182A1 (en) * 1996-07-12 1998-01-22 Novartis Consumer Health S.A. Oral pharmaceutical combinations of nsaids with terpenoids
US5725865A (en) * 1995-08-29 1998-03-10 V. Mane Fils S.A. Coolant compositions
US5752529A (en) * 1996-08-21 1998-05-19 V. Mane Fils S.A. Tobacco products containing coolant compositions
US5783725A (en) * 1996-02-27 1998-07-21 Haarmann & Reimer Gmbh Stabilized lactic acid menthyl ester
US5843466A (en) * 1995-08-29 1998-12-01 V. Mane Fils S.A. Coolant compositions
US5977166A (en) * 1990-11-06 1999-11-02 Wm. Wrigley Jr. Company Enhanced flavors using menthone ketals
US6214788B1 (en) 1999-03-31 2001-04-10 Firmenich Sa Use of cubebol as a flavoring ingredient
US6277385B1 (en) 1992-06-17 2001-08-21 The Procter & Gamble Company Cooling compositions with reduced stinging
US6359168B1 (en) 1997-11-27 2002-03-19 Firmenich Sa Compounds derived from menthol and use as refreshing agent
WO2002032388A3 (en) * 2000-10-16 2002-08-22 Colgate Palmolive Co Oral compositions for reducing mouth odors
US6455080B1 (en) 1997-12-29 2002-09-24 Wm. Wrigley Jr., Company Chewing gum containing controlled release acyclic carboxamide and method of making
EP1250941A1 (en) * 2001-04-17 2002-10-23 The Procter & Gamble Company Articles comprising a mint odor-free cooling agent
EP1250940A1 (en) * 2001-04-17 2002-10-23 The Procter & Gamble Company An absorbent article comprising an agent able to convey a perception to the wearer
US6627233B1 (en) 1997-09-18 2003-09-30 Wm. Wrigley Jr. Company Chewing gum containing physiological cooling agents
US7025997B2 (en) 2003-09-24 2006-04-11 International Flavors & Fragrances Inc. Coolant plant extract compositions containing monomenthyl succinate
EP1716837A1 (en) 2005-02-28 2006-11-02 The Procter & Gamble Company Use of a volatile cooling sensate on fibrous tissues to provide a sensation of rhinological decongestion
EP1935252A1 (en) 1997-09-18 2008-06-25 WM. Wrigley Jr., Company Chewing gum composition
EP2033688A2 (en) 2007-08-20 2009-03-11 Symrise GmbH & Co. KG Oxalic acid derivatives and their use as physiological cooling agents
US7803963B2 (en) 2007-10-15 2010-09-28 Millennium Specialty Chemicals, Inc. Physiological coolants based on lactoyl esters of menthyl lactate
WO2010149798A3 (en) * 2010-06-14 2011-04-14 Symrise Ag Use of polyols for enhancing the cooling effect of a cooling substance and cooling mixtures having an enhanced cooling effect
WO2011061330A2 (en) 2009-11-20 2011-05-26 Symrise Ag Use of physiological cooling active ingredients, and agents containing such active ingredients
EP2478777A1 (en) 2005-12-23 2012-07-25 Kraft Foods Global Brands LLC Composition providing a cooling sensation substantially similar to that provided by menthol
US8273367B2 (en) 2001-04-17 2012-09-25 The Procter And Gamble Company Articles comprising a mint odor-free cooling agent
US8343945B2 (en) 2007-12-07 2013-01-01 Foamix Ltd. Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
US8362091B2 (en) 2003-08-04 2013-01-29 Foamix Ltd. Foamable vehicle and pharmaceutical compositions thereof
EP2559424A1 (en) 2005-10-05 2013-02-20 Kraft Foods Global Brands LLC Cooling composition comprising trimethyl isopropyl butanamide
WO2013041621A1 (en) 2011-09-20 2013-03-28 Basf Se Low molecular weight modulators of the cold-menthol receptor trpm8 and use thereof
US8435498B2 (en) 2002-10-25 2013-05-07 Foamix Ltd. Penetrating pharmaceutical foam
US8486374B2 (en) 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
US8486375B2 (en) 2003-04-28 2013-07-16 Foamix Ltd. Foamable compositions
US8486376B2 (en) 2002-10-25 2013-07-16 Foamix Ltd. Moisturizing foam containing lanolin
EP2620137A1 (en) 2012-01-30 2013-07-31 Symrise AG Compositions
US8512718B2 (en) 2000-07-03 2013-08-20 Foamix Ltd. Pharmaceutical composition for topical application
US8518376B2 (en) 2007-12-07 2013-08-27 Foamix Ltd. Oil-based foamable carriers and formulations
US8518378B2 (en) 2003-08-04 2013-08-27 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
WO2013171018A2 (en) 2012-05-16 2013-11-21 Symrise Ag Mixtures having improved cooling effect
US8618081B2 (en) 2009-10-02 2013-12-31 Foamix Ltd. Compositions, gels and foams with rheology modulators and uses thereof
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
US8709385B2 (en) 2008-01-14 2014-04-29 Foamix Ltd. Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
US8722021B2 (en) 2002-10-25 2014-05-13 Foamix Ltd. Foamable carriers
WO2014090293A1 (en) 2012-12-12 2014-06-19 Symrise Ag Preparations
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
US8795635B2 (en) 2006-11-14 2014-08-05 Foamix Ltd. Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
EP2801263A1 (en) 2013-05-09 2014-11-12 Symrise AG Cooling composition
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
EP2423290A4 (en) * 2009-04-24 2015-05-27 Takasago Perfumery Co Ltd Process for producing 1-menthyl (3s)-3-hydroxybutanoate and composition for stimulating sense
US9072667B2 (en) 2009-07-29 2015-07-07 Foamix Pharmaceuticals Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
US9167813B2 (en) 2009-07-29 2015-10-27 Foamix Pharmaceuticals Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
EP1250914B2 (en) 2001-04-17 2015-11-25 The Procter & Gamble Company Cooling compositions
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
EP2962679A1 (en) 2014-06-30 2016-01-06 Symrise AG Use of tetrahydrofuranlignans
EP2979751A1 (en) 2014-07-29 2016-02-03 Symrise AG Process for the manufacturing of solid cooling agents
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US9320705B2 (en) 2002-10-25 2016-04-26 Foamix Pharmaceuticals Ltd. Sensation modifying topical composition foam
DE202012013357U1 (en) 2012-12-12 2016-07-29 Symrise Ag preparations
EP3059009A1 (en) 2015-02-19 2016-08-24 Symrise AG Process for the storage of refreshing agents
WO2016139066A1 (en) 2015-03-04 2016-09-09 Symrise Ag Compositions comprising menthol compounds as soothing agents
US9439857B2 (en) 2007-11-30 2016-09-13 Foamix Pharmaceuticals Ltd. Foam containing benzoyl peroxide
US9539208B2 (en) 2002-10-25 2017-01-10 Foamix Pharmaceuticals Ltd. Foam prepared from nanoemulsions and uses
US9622947B2 (en) 2002-10-25 2017-04-18 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
WO2017190789A1 (en) 2016-05-05 2017-11-09 Symrise Ag Coolant mixtures
WO2017198284A1 (en) 2016-05-14 2017-11-23 Symrise Ag Menthol-containing aroma preparations
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
US9884017B2 (en) 2009-04-28 2018-02-06 Foamix Pharmaceuticals Ltd. Foamable vehicles and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
WO2019043164A1 (en) 2017-08-31 2019-03-07 Basf Se Use of physiological cooling active ingredients, and compositions comprising such active ingredients
US10398641B2 (en) 2016-09-08 2019-09-03 Foamix Pharmaceuticals Ltd. Compositions and methods for treating rosacea and acne
US10722434B2 (en) * 2015-05-15 2020-07-28 Symrise Ag Liquid cooling compositions
EP3689324A1 (en) 2019-02-04 2020-08-05 Symrise AG New cooling agents and preparations comprising them
WO2022105986A1 (en) 2020-11-17 2022-05-27 Symrise Ag Novel cooling agents and preparations containing same
WO2022122144A1 (en) 2020-12-09 2022-06-16 Symrise Ag A method for fighting microorganisms using menthol derivatives
WO2022207944A2 (en) 2022-07-11 2022-10-06 Symrise Ag Novel mixtures and uses of (2e)-3-(1,3-benzodioxol-5-yl)-n-phenyl-n-(tetrahydro-3-furanyl)-2-propenamide
WO2022258189A1 (en) 2021-06-10 2022-12-15 Symrise Ag Compositions for fighting malodors
WO2023021012A1 (en) 2021-08-16 2023-02-23 Symrise Ag Compositions
WO2023083445A1 (en) 2021-11-10 2023-05-19 Symrise Ag Compositions comprising trpm8 agonistic cooling agents
WO2023131667A1 (en) 2022-01-07 2023-07-13 V. Mane Fils Cooling compounds and compositions
WO2023143741A1 (en) 2022-01-28 2023-08-03 Symrise Ag New coolants, and preparations containing same
WO2023147852A1 (en) 2022-02-02 2023-08-10 Symrise Ag Compositions (iii)
WO2023222577A1 (en) 2022-05-18 2023-11-23 Symrise Ag Antimicrobial mixtures

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63170123A (en) * 1986-12-29 1988-07-14 Nippon Denso Co Ltd Air conditioning device
JPH01149710A (en) * 1987-12-07 1989-06-12 Sunstar Inc Detergent composition
FR2788695B1 (en) * 1999-01-22 2002-09-06 Roc Sa COSMETIC COMPOSITION BASED ON MENTHOL AND MENTHYL LACTATE, SMALL ODORANT AND NON-IRRITANT
CN107532063B (en) 2015-03-25 2020-03-10 高砂香料工业株式会社 Methylmenthol derivative and cold-sensitive composition containing the same

Cited By (152)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5977166A (en) * 1990-11-06 1999-11-02 Wm. Wrigley Jr. Company Enhanced flavors using menthone ketals
US5266592A (en) * 1991-04-05 1993-11-30 Haarmann & Reimer Gmbh Compositions which have a physiological cooling effect, and active compounds suitable for these compositions
US6277385B1 (en) 1992-06-17 2001-08-21 The Procter & Gamble Company Cooling compositions with reduced stinging
WO1996014840A1 (en) * 1994-11-14 1996-05-23 Zyma S.A. Use of menthyl lactate as a pain reliever
WO1997002116A1 (en) * 1995-06-30 1997-01-23 The Gillette Company Shaving aid composite with a non-volatile cooling agent
WO1997007771A1 (en) * 1995-08-29 1997-03-06 V. Mane Fils S.A. Refreshing compositions
US5843466A (en) * 1995-08-29 1998-12-01 V. Mane Fils S.A. Coolant compositions
US5725865A (en) * 1995-08-29 1998-03-10 V. Mane Fils S.A. Coolant compositions
US5783725A (en) * 1996-02-27 1998-07-21 Haarmann & Reimer Gmbh Stabilized lactic acid menthyl ester
WO1997042944A1 (en) * 1996-05-13 1997-11-20 Novartis Consumer Health S.A. Topical composition
WO1997042945A1 (en) * 1996-05-13 1997-11-20 Novartis Consumer Health S.A. Oral pharmaceutical compositions
WO1998002182A1 (en) * 1996-07-12 1998-01-22 Novartis Consumer Health S.A. Oral pharmaceutical combinations of nsaids with terpenoids
US5752529A (en) * 1996-08-21 1998-05-19 V. Mane Fils S.A. Tobacco products containing coolant compositions
US6627233B1 (en) 1997-09-18 2003-09-30 Wm. Wrigley Jr. Company Chewing gum containing physiological cooling agents
EP1935252A1 (en) 1997-09-18 2008-06-25 WM. Wrigley Jr., Company Chewing gum composition
US6359168B1 (en) 1997-11-27 2002-03-19 Firmenich Sa Compounds derived from menthol and use as refreshing agent
US6455080B1 (en) 1997-12-29 2002-09-24 Wm. Wrigley Jr., Company Chewing gum containing controlled release acyclic carboxamide and method of making
US6214788B1 (en) 1999-03-31 2001-04-10 Firmenich Sa Use of cubebol as a flavoring ingredient
US8512718B2 (en) 2000-07-03 2013-08-20 Foamix Ltd. Pharmaceutical composition for topical application
WO2002032388A3 (en) * 2000-10-16 2002-08-22 Colgate Palmolive Co Oral compositions for reducing mouth odors
EP1250941A1 (en) * 2001-04-17 2002-10-23 The Procter & Gamble Company Articles comprising a mint odor-free cooling agent
US8273367B2 (en) 2001-04-17 2012-09-25 The Procter And Gamble Company Articles comprising a mint odor-free cooling agent
EP1250914B2 (en) 2001-04-17 2015-11-25 The Procter & Gamble Company Cooling compositions
WO2002083192A1 (en) * 2001-04-17 2002-10-24 The Procter & Gamble Company Articles comprising a mint odor-free cooling agent
WO2002083191A1 (en) * 2001-04-17 2002-10-24 The Procter & Gamble Company An absorbent article comprising an agent able to convey a perception to the wearer
EP1250940A1 (en) * 2001-04-17 2002-10-23 The Procter & Gamble Company An absorbent article comprising an agent able to convey a perception to the wearer
CN100540063C (en) * 2001-04-17 2009-09-16 宝洁公司 The goods that comprise the cool agent that does not contain mint smell
CN1501816B (en) * 2001-04-17 2010-05-26 宝洁公司 An absorbent article comprising an agent able to convey a perception to the wearer
US8435498B2 (en) 2002-10-25 2013-05-07 Foamix Ltd. Penetrating pharmaceutical foam
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US9492412B2 (en) 2002-10-25 2016-11-15 Foamix Pharmaceuticals Ltd. Penetrating pharmaceutical foam
US11033491B2 (en) 2002-10-25 2021-06-15 Vyne Therapeutics Inc. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US9539208B2 (en) 2002-10-25 2017-01-10 Foamix Pharmaceuticals Ltd. Foam prepared from nanoemulsions and uses
US9622947B2 (en) 2002-10-25 2017-04-18 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US9320705B2 (en) 2002-10-25 2016-04-26 Foamix Pharmaceuticals Ltd. Sensation modifying topical composition foam
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US8741265B2 (en) 2002-10-25 2014-06-03 Foamix Ltd. Penetrating pharmaceutical foam
US8722021B2 (en) 2002-10-25 2014-05-13 Foamix Ltd. Foamable carriers
US9713643B2 (en) 2002-10-25 2017-07-25 Foamix Pharmaceuticals Ltd. Foamable carriers
US10821077B2 (en) 2002-10-25 2020-11-03 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US8840869B2 (en) 2002-10-25 2014-09-23 Foamix Ltd. Body cavity foams
US8486376B2 (en) 2002-10-25 2013-07-16 Foamix Ltd. Moisturizing foam containing lanolin
US10322085B2 (en) 2002-10-25 2019-06-18 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US8486375B2 (en) 2003-04-28 2013-07-16 Foamix Ltd. Foamable compositions
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
US9050253B2 (en) 2003-08-04 2015-06-09 Foamix Pharmaceuticals Ltd. Oleaginous pharmaceutical and cosmetic foam
US8362091B2 (en) 2003-08-04 2013-01-29 Foamix Ltd. Foamable vehicle and pharmaceutical compositions thereof
US8703105B2 (en) 2003-08-04 2014-04-22 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US8518378B2 (en) 2003-08-04 2013-08-27 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US8486374B2 (en) 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
US9636405B2 (en) 2003-08-04 2017-05-02 Foamix Pharmaceuticals Ltd. Foamable vehicle and pharmaceutical compositions thereof
US9101662B2 (en) 2003-08-04 2015-08-11 Foamix Pharmaceuticals Ltd. Compositions with modulating agents
US7025997B2 (en) 2003-09-24 2006-04-11 International Flavors & Fragrances Inc. Coolant plant extract compositions containing monomenthyl succinate
EP1716837A1 (en) 2005-02-28 2006-11-02 The Procter & Gamble Company Use of a volatile cooling sensate on fibrous tissues to provide a sensation of rhinological decongestion
EP2559424A1 (en) 2005-10-05 2013-02-20 Kraft Foods Global Brands LLC Cooling composition comprising trimethyl isopropyl butanamide
EP2478777A1 (en) 2005-12-23 2012-07-25 Kraft Foods Global Brands LLC Composition providing a cooling sensation substantially similar to that provided by menthol
US9682021B2 (en) 2006-11-14 2017-06-20 Foamix Pharmaceuticals Ltd. Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US8795635B2 (en) 2006-11-14 2014-08-05 Foamix Ltd. Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
US10369102B2 (en) 2007-08-07 2019-08-06 Foamix Pharmaceuticals Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
US9662298B2 (en) 2007-08-07 2017-05-30 Foamix Pharmaceuticals Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
US11103454B2 (en) 2007-08-07 2021-08-31 Vyne Therapeutics Inc. Wax foamable vehicle and pharmaceutical compositions thereof
EP2033688A2 (en) 2007-08-20 2009-03-11 Symrise GmbH & Co. KG Oxalic acid derivatives and their use as physiological cooling agents
US8344025B2 (en) 2007-08-20 2013-01-01 Symrise Ag Oxalic acid derivatives and use thereof as physiological cooling active ingredients
US7803963B2 (en) 2007-10-15 2010-09-28 Millennium Specialty Chemicals, Inc. Physiological coolants based on lactoyl esters of menthyl lactate
US7968744B2 (en) 2007-10-15 2011-06-28 Renessenz, Llc Physiological coolants based on lactoyl esters of menthyl lactate
US9439857B2 (en) 2007-11-30 2016-09-13 Foamix Pharmaceuticals Ltd. Foam containing benzoyl peroxide
US11433025B2 (en) 2007-12-07 2022-09-06 Vyne Therapeutics Inc. Oil foamable carriers and formulations
US9161916B2 (en) 2007-12-07 2015-10-20 Foamix Pharmaceuticals Ltd. Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
US9795564B2 (en) 2007-12-07 2017-10-24 Foamix Pharmaceuticals Ltd. Oil-based foamable carriers and formulations
US8900553B2 (en) 2007-12-07 2014-12-02 Foamix Pharmaceuticals Ltd. Oil and liquid silicone foamable carriers and formulations
US8343945B2 (en) 2007-12-07 2013-01-01 Foamix Ltd. Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
US8518376B2 (en) 2007-12-07 2013-08-27 Foamix Ltd. Oil-based foamable carriers and formulations
US9549898B2 (en) 2007-12-07 2017-01-24 Foamix Pharmaceuticals Ltd. Oil and liquid silicone foamable carriers and formulations
US8709385B2 (en) 2008-01-14 2014-04-29 Foamix Ltd. Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
EP2423290A4 (en) * 2009-04-24 2015-05-27 Takasago Perfumery Co Ltd Process for producing 1-menthyl (3s)-3-hydroxybutanoate and composition for stimulating sense
US9884017B2 (en) 2009-04-28 2018-02-06 Foamix Pharmaceuticals Ltd. Foamable vehicles and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
US10213384B2 (en) 2009-04-28 2019-02-26 Foamix Pharmaceuticals Ltd. Foamable vehicles and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
US10588858B2 (en) 2009-04-28 2020-03-17 Foamix Pharmaceuticals Ltd. Foamable vehicles and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
US10363216B2 (en) 2009-04-28 2019-07-30 Foamix Pharmaceuticals Ltd. Foamable vehicles and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
US10350166B2 (en) 2009-07-29 2019-07-16 Foamix Pharmaceuticals Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
US9167813B2 (en) 2009-07-29 2015-10-27 Foamix Pharmaceuticals Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
US11219631B2 (en) 2009-07-29 2022-01-11 Vyne Pharmaceuticals Inc. Foamable compositions, breakable foams and their uses
US10092588B2 (en) 2009-07-29 2018-10-09 Foamix Pharmaceuticals Ltd. Foamable compositions, breakable foams and their uses
US9572775B2 (en) 2009-07-29 2017-02-21 Foamix Pharmaceuticals Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
US9072667B2 (en) 2009-07-29 2015-07-07 Foamix Pharmaceuticals Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
US10517882B2 (en) 2009-10-02 2019-12-31 Foamix Pharmaceuticals Ltd. Method for healing of an infected acne lesion without scarring
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
US10967063B2 (en) 2009-10-02 2021-04-06 Vyne Therapeutics Inc. Surfactant-free, water-free formable composition and breakable foams and their uses
US9675700B2 (en) 2009-10-02 2017-06-13 Foamix Pharmaceuticals Ltd. Topical tetracycline compositions
US10835613B2 (en) 2009-10-02 2020-11-17 Foamix Pharmaceuticals Ltd. Compositions, gels and foams with rheology modulators and uses thereof
US8992896B2 (en) 2009-10-02 2015-03-31 Foamix Pharmaceuticals Ltd. Topical tetracycline compositions
US10821187B2 (en) 2009-10-02 2020-11-03 Foamix Pharmaceuticals Ltd. Compositions, gels and foams with rheology modulators and uses thereof
US8865139B1 (en) 2009-10-02 2014-10-21 Foamix Pharmaceuticals Ltd. Topical tetracycline compositions
US8945516B2 (en) 2009-10-02 2015-02-03 Foamix Pharmaceuticals Ltd. Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
US10265404B2 (en) 2009-10-02 2019-04-23 Foamix Pharmaceuticals Ltd. Compositions, gels and foams with rheology modulators and uses thereof
US10946101B2 (en) 2009-10-02 2021-03-16 Vyne Therapeutics Inc. Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
US10322186B2 (en) 2009-10-02 2019-06-18 Foamix Pharmaceuticals Ltd. Topical tetracycline compositions
US10238746B2 (en) 2009-10-02 2019-03-26 Foamix Pharmaceuticals Ltd Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
US10610599B2 (en) 2009-10-02 2020-04-07 Foamix Pharmaceuticals Ltd. Topical tetracycline compositions
US10086080B2 (en) 2009-10-02 2018-10-02 Foamix Pharmaceuticals Ltd. Topical tetracycline compositions
US10029013B2 (en) 2009-10-02 2018-07-24 Foamix Pharmaceuticals Ltd. Surfactant-free, water-free formable composition and breakable foams and their uses
US10463742B2 (en) 2009-10-02 2019-11-05 Foamix Pharmaceuticals Ltd. Topical tetracycline compositions
US10137200B2 (en) 2009-10-02 2018-11-27 Foamix Pharmaceuticals Ltd. Surfactant-free water-free foamable compositions, breakable foams and gels and their uses
US10213512B2 (en) 2009-10-02 2019-02-26 Foamix Pharmaceuticals Ltd. Topical tetracycline compositions
US8871184B2 (en) 2009-10-02 2014-10-28 Foamix Ltd. Topical tetracycline compositions
US8618081B2 (en) 2009-10-02 2013-12-31 Foamix Ltd. Compositions, gels and foams with rheology modulators and uses thereof
EP3663366A2 (en) 2009-11-20 2020-06-10 Symrise AG Use of physiological cooling ingredients and agents containing such active ingredients
WO2011061330A2 (en) 2009-11-20 2011-05-26 Symrise Ag Use of physiological cooling active ingredients, and agents containing such active ingredients
DE102010002558A1 (en) 2009-11-20 2011-06-01 Symrise Ag Use of physiological cooling agents and agents containing such agents
US11491091B2 (en) 2010-06-14 2022-11-08 Symrise Ag Cooling product
WO2010149798A3 (en) * 2010-06-14 2011-04-14 Symrise Ag Use of polyols for enhancing the cooling effect of a cooling substance and cooling mixtures having an enhanced cooling effect
WO2013041621A1 (en) 2011-09-20 2013-03-28 Basf Se Low molecular weight modulators of the cold-menthol receptor trpm8 and use thereof
EP2620137A1 (en) 2012-01-30 2013-07-31 Symrise AG Compositions
EP3219303A1 (en) 2012-01-30 2017-09-20 Symrise AG Compositions
US9743685B2 (en) 2012-05-16 2017-08-29 Symrise Ag Mixtures having improved cooling effect
WO2013171018A2 (en) 2012-05-16 2013-11-21 Symrise Ag Mixtures having improved cooling effect
WO2014090293A1 (en) 2012-12-12 2014-06-19 Symrise Ag Preparations
DE202012013357U1 (en) 2012-12-12 2016-07-29 Symrise Ag preparations
EP2801263A1 (en) 2013-05-09 2014-11-12 Symrise AG Cooling composition
DE102014006596A1 (en) 2013-05-09 2014-11-13 Symrise Ag Cooling composition
EP2962679A1 (en) 2014-06-30 2016-01-06 Symrise AG Use of tetrahydrofuranlignans
EP2979751A1 (en) 2014-07-29 2016-02-03 Symrise AG Process for the manufacturing of solid cooling agents
EP4015075A1 (en) 2015-02-19 2022-06-22 Symrise AG Standard packages with fixed cooling materials
EP3059009A1 (en) 2015-02-19 2016-08-24 Symrise AG Process for the storage of refreshing agents
WO2016131710A1 (en) 2015-02-19 2016-08-25 Symrise Ag Method for storing cooling agents
WO2016139066A1 (en) 2015-03-04 2016-09-09 Symrise Ag Compositions comprising menthol compounds as soothing agents
US10722434B2 (en) * 2015-05-15 2020-07-28 Symrise Ag Liquid cooling compositions
WO2017190789A1 (en) 2016-05-05 2017-11-09 Symrise Ag Coolant mixtures
WO2017198284A1 (en) 2016-05-14 2017-11-23 Symrise Ag Menthol-containing aroma preparations
US11324691B2 (en) 2016-09-08 2022-05-10 Journey Medical Corporation Compositions and methods for treating rosacea and acne
US10849847B2 (en) 2016-09-08 2020-12-01 Foamix Pharamaceuticals Ltd. Compositions and methods for treating rosacea and acne
US10398641B2 (en) 2016-09-08 2019-09-03 Foamix Pharmaceuticals Ltd. Compositions and methods for treating rosacea and acne
US11434220B2 (en) 2017-08-31 2022-09-06 Basf Se Use of physiological cooling active ingredients, and compositions comprising such active ingredients
WO2019043164A1 (en) 2017-08-31 2019-03-07 Basf Se Use of physiological cooling active ingredients, and compositions comprising such active ingredients
EP3689324A1 (en) 2019-02-04 2020-08-05 Symrise AG New cooling agents and preparations comprising them
WO2022105986A1 (en) 2020-11-17 2022-05-27 Symrise Ag Novel cooling agents and preparations containing same
WO2022106452A2 (en) 2020-11-17 2022-05-27 Symrise Ag New coolants, and preparations containing same
WO2022122144A1 (en) 2020-12-09 2022-06-16 Symrise Ag A method for fighting microorganisms using menthol derivatives
WO2022258189A1 (en) 2021-06-10 2022-12-15 Symrise Ag Compositions for fighting malodors
WO2023021012A1 (en) 2021-08-16 2023-02-23 Symrise Ag Compositions
WO2023083445A1 (en) 2021-11-10 2023-05-19 Symrise Ag Compositions comprising trpm8 agonistic cooling agents
WO2023131667A1 (en) 2022-01-07 2023-07-13 V. Mane Fils Cooling compounds and compositions
WO2023143741A1 (en) 2022-01-28 2023-08-03 Symrise Ag New coolants, and preparations containing same
WO2023144326A1 (en) 2022-01-28 2023-08-03 Symrise Ag New coolants, and preparations containing same
WO2023147852A1 (en) 2022-02-02 2023-08-10 Symrise Ag Compositions (iii)
WO2023222577A1 (en) 2022-05-18 2023-11-23 Symrise Ag Antimicrobial mixtures
WO2023222213A1 (en) 2022-05-18 2023-11-23 Symrise Ag Antimicrobial mixtures
WO2022207944A2 (en) 2022-07-11 2022-10-06 Symrise Ag Novel mixtures and uses of (2e)-3-(1,3-benzodioxol-5-yl)-n-phenyl-n-(tetrahydro-3-furanyl)-2-propenamide

Also Published As

Publication number Publication date
JPS52105223A (en) 1977-09-03
FR2342057A1 (en) 1977-09-23
NL7702074A (en) 1977-08-30

Similar Documents

Publication Publication Date Title
DE2608226A1 (en) AGENTS WITH PHYSIOLOGICAL COOLING EFFECT
DE2202535C3 (en) Use of p-menthan derivatives
DE2205255C3 (en) N-substituted p-menthane-3-carboxamides and agents containing them for stimulating the cold receptors of the nervous system
DE2516610C2 (en) Consumable product with a physiological cooling effect
DE2433165C2 (en) N-acetylglycine-1-menthyl ester, process for its preparation and dentifrices containing this ester
DE2366423C2 (en) Use of carboxamides as cold receptor stimulants for objects or means with a cooling effect
US4034109A (en) Compounds having a physiological cooling effect and compositions containing them
DE60126451T2 (en) Method and means for improving the diffusion and persistence properties of a perfume
DE1917393A1 (en) Perfumed and flavored products
DE69920567T2 (en) Method of preventing the body odor of old people
US3644613A (en) Oral. nasal and labial compositions containing menthyl keto esters
DE2624504A1 (en) COMPOUND OR OBJECTIVE WITH A STIMULATING EFFECT TO THE COLD RECEPTORS OF THE HUMAN NERVOUS SYSTEM
DE1667871A1 (en) Liquid dentifrices containing abrasives
DE60001918T2 (en) COSMETIC COMPOSITION BASED ON MENTHOL AND MENTHYL LACTATE, WHICH HAS A LOW SMELL AND IS NOT IRRITANT
CA1041506A (en) Compounds having a physiological cooling effect and compositions containing them
EP0306853B1 (en) Cosmetic composition with germicidal properties
DE2439770A1 (en) AGENTS WITH PHYSIOLOGICAL COOLING EFFECT
DE2317539C2 (en) Cyclohexanecarboxamides and their use as agents for stimulating the cold receptors of the human nervous system
DE2458562C2 (en) Consumable product with a compound that stimulates the cold receptors of the nervous system
US3793446A (en) Oral,nasal and labial compositions containing menthyl keto esters
DE2317000A1 (en) Means of stimulating the cold receptors of the human nervous system and their use
DE2316999A1 (en) Means of stimulating the cold receptors of the human nervous system and their use
DE2456639A1 (en) Sprayable ester contg deodorant compsn - prevents container corrosion without reducing bacteriostatic activity
DE2012328A1 (en)
EP2026750B1 (en) Denaturing agent for ethanol and its cosmetic or oral hygienic product

Legal Events

Date Code Title Description
OHN Withdrawal